CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Planned sale Chief Legal Officer sold 49,024 shares at $1.45 ($71,085)
- 4 Planned sale Chief Operating Officer sold 75,989 shares at $1.45 ($110,184)
- 4 Planned sale President and CEO sold 193,913 shares at $1.45 ($281,174)
- 4 Planned sale Chief Financial Officer sold 59,887 shares at $1.45 ($86,836)
- 4 Planned sale Chief Medical Officer sold 49,024 shares at $1.45 ($71,085)
- 4 Planned sale Chief Legal Officer sold 27,457 shares at $1.50 ($41,131)
- 4 Planned sale Chief Operating Officer sold 33,999 shares at $1.50 ($50,931)
- 4 Planned sale President and CEO sold 60,984 shares at $1.50 ($91,354)
- 4 Planned sale Chief Financial Officer sold 31,148 shares at $1.50 ($46,660)
- 4 Planned sale Chief Medical Officer sold 26,139 shares at $1.50 ($39,156)
- 4 Planned sale Chief Legal Officer sold 66,292 shares at an average $1.58 ($104,885)
- 4 Planned sale Chief Operating Officer sold 10,780 shares at $1.55 ($16,693)
- 4 Planned sale President and CEO sold 23,023 shares at $1.55 ($35,651)
- 4 Planned sale Chief Financial Officer sold 69,042 shares at an average $1.57 ($108,658)
- 4 Planned sale Chief Medical Officer sold 57,546 shares at an average $1.57 ($90,571)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 36 · 701 filings